EUVIMEDEUVIMED entdecken
Crossref

Unapproved GLP-1 Drugs Retatrutide and Zenagamtide Sold Online Are No Bargain

Rita Rubin

JAMA · 03.11.2026 · 336 (17) · 1493

DOI: 10.1001/jama.2026.20514 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA, erschienen am 03.11.2026. Verfasst von Rita Rubin. Beteiligte Einrichtung: Lead Senior Staff Writer, Medical News, JAMA.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This Medical News article discusses the reasons behind the burgeoning black market for 2 unapproved GLP-1 weight loss drugs and the potential risks associated with their use.

Autor:innen und Institutionen

  • Lead Senior Staff Writer, Medical News, JAMA.

Zitieren

APA

Rubin, R. (2026). Unapproved GLP-1 Drugs Retatrutide and Zenagamtide Sold Online Are No Bargain. JAMA, 336(17), 1493. https://doi.org/10.1001/jama.2026.20514

Vancouver

Rubin R. Unapproved GLP-1 Drugs Retatrutide and Zenagamtide Sold Online Are No Bargain. JAMA. 2026;336(17):1493. doi:10.1001/jama.2026.20514

BibTeX
@article{Rubin2026,
  author = {Rubin, Rita},
  title = {Unapproved GLP-1 Drugs Retatrutide and Zenagamtide Sold Online Are No Bargain},
  journal = {JAMA},
  year = {2026},
  volume = {336},
  number = {17},
  pages = {1493},
  doi = {10.1001/jama.2026.20514}
}
Kostenlos starten →